
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17805020
[patent_doc_number] => 20220256855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES
[patent_app_type] => utility
[patent_app_number] => 17/629344
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629344 | Picolinamide derivatives useful as agricultural fungicides | Jul 22, 2020 | Issued |
Array
(
[id] => 16557140
[patent_doc_number] => 20210002288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => INDAZOLE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/934308
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16934308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/934308 | Indazole compounds and uses thereof | Jul 20, 2020 | Issued |
Array
(
[id] => 17922749
[patent_doc_number] => 11465982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Pyridazines
[patent_app_type] => utility
[patent_app_number] => 16/932886
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12190
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932886 | Pyridazines | Jul 19, 2020 | Issued |
Array
(
[id] => 18384470
[patent_doc_number] => 11655239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/628246
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 31
[patent_no_of_words] => 34961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628246 | Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof | Jul 16, 2020 | Issued |
Array
(
[id] => 18405731
[patent_doc_number] => 20230167082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => PRODRUGS IN THE MODULATION OF INTERLEUKIN
[patent_app_type] => utility
[patent_app_number] => 17/627169
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627169 | Prodrugs in the modulation of interleukin | Jul 13, 2020 | Issued |
Array
(
[id] => 17193094
[patent_doc_number] => 11161835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Compounds and their use for reducing uric acid levels
[patent_app_type] => utility
[patent_app_number] => 16/928629
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18523
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928629 | Compounds and their use for reducing uric acid levels | Jul 13, 2020 | Issued |
Array
(
[id] => 16398955
[patent_doc_number] => 20200339813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => NOVEL METHINE DYES
[patent_app_type] => utility
[patent_app_number] => 16/927475
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927475 | NOVEL METHINE DYES | Jul 12, 2020 | Abandoned |
Array
(
[id] => 16398734
[patent_doc_number] => 20200339592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/924750
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16924750
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/924750 | KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION | Jul 8, 2020 | Abandoned |
Array
(
[id] => 16389536
[patent_doc_number] => 20200330477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => AMINOPYRIMIDINYL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/920027
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920027 | Aminopyrimidinyl compounds | Jul 1, 2020 | Issued |
Array
(
[id] => 18140387
[patent_doc_number] => 20230014226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NEW COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/622543
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622543 | NEW COMPOUNDS AND METHODS | Jun 23, 2020 | Abandoned |
Array
(
[id] => 20357281
[patent_doc_number] => 12473264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/620043
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 12836
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620043 | Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof | Jun 17, 2020 | Issued |
Array
(
[id] => 17791977
[patent_doc_number] => 20220251068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => PYRIDIN-3-YL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/620520
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620520 | Pyridin-3-yl derivatives | Jun 16, 2020 | Issued |
Array
(
[id] => 16512860
[patent_doc_number] => 20200392118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => DISUBSTITUTED PYRAZOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/902806
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902806 | Disubstituted pyrazole compounds | Jun 15, 2020 | Issued |
Array
(
[id] => 16540903
[patent_doc_number] => 20200407316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/895671
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895671 | SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS | Jun 7, 2020 | Abandoned |
Array
(
[id] => 19180991
[patent_doc_number] => 11987572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Therapeutic compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/892072
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 36284
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892072 | Therapeutic compounds and methods of use thereof | Jun 2, 2020 | Issued |
Array
(
[id] => 18666222
[patent_doc_number] => 11773099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Compounds and their methods of use
[patent_app_type] => utility
[patent_app_number] => 16/885605
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28456
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885605 | Compounds and their methods of use | May 27, 2020 | Issued |
Array
(
[id] => 17774892
[patent_doc_number] => 20220241241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => OXALAMIDO-SUBSTITUTED TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/611777
[patent_app_country] => US
[patent_app_date] => 2020-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611777 | Oxalamido-substituted tricyclic inhibitors of hepatitis b virus | May 24, 2020 | Issued |
Array
(
[id] => 17748083
[patent_doc_number] => 20220226286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT AND MITIGATION OF ALCOHOL-INDUCED SKIN FLUSHING
[patent_app_type] => utility
[patent_app_number] => 17/613680
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613680 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND MITIGATION OF ALCOHOL-INDUCED SKIN FLUSHING | May 21, 2020 | Pending |
Array
(
[id] => 16570589
[patent_doc_number] => 20210009595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PYRAZOLOPYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/880192
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880192 | PYRAZOLOPYRIMIDINE COMPOUNDS | May 20, 2020 | Abandoned |
Array
(
[id] => 16437025
[patent_doc_number] => 20200354351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
[patent_app_type] => utility
[patent_app_number] => 16/877291
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877291 | Compositions and methods for viral sensitization | May 17, 2020 | Issued |